Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Warsaw - Delayed Quote • PLN Selvita S.A. (SLV.WA) Follow Add holdings 33.00 +0.70 +(2.17%) At close: April 25 at 5:00:00 PM GMT+2 All News Press Releases SEC Filings 3 Growth Stocks With High Insider Ownership And Up To 61% Earnings Growth As global markets navigate the challenges of rising U.S. Treasury yields and tepid economic growth, investors are increasingly focused on growth stocks that can outperform in uncertain conditions. In this environment, companies with high insider ownership often stand out as they signal strong confidence from those who know the business best, making them appealing options for those seeking potential earnings growth amidst market volatility. Selvita reports growing sales in Q2 and Q3, and projects increased profitability in H2 2024 Selvita S.A. (WSE: SLV), one of the leading preclinical contract research organizations in Europe, has published its financial results for Q2 2024, earnings estimates for Q3 204 and backlog for 2024 and 2025. Selvita completes acquisition of PozLab and significantly expands its drug development capabilities Selvita S.A. [WSE: SLV] announced today completion of a strategic transaction in which it has acquired 100% of shares in PozLab. The closing of the transaction comes shortly after the announcement of the transaction on March 27, 2024. Performance Overview Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) Return SLV.WA MSCI WORLD (^990100-USD-STRD) YTD -33.33% -2.70% 1-Year -52.17% +8.88% 3-Year -58.65% --